PDCD1 and Miyoshi myopathy: The analysis of the three time points of the EVs isolated from RES > PRO evidenced at the progression time the anti-PD1 treatment seemed to increase the invasive characteristics mainly in BRAFwt MM cells (Fig. 3A).